How to Choose IVF in the U.S., Mexico, or Japan: Fresh Embryos, Frozen Embryos, and Blastocysts Explained

During IVF treatment, there are different decisions to make at every stage, from egg retrieval and fertilization to embryo transfer. Terms such as fresh embryos, frozen embryos, and blastocysts frequently appear in treatment plans and medical reports, and they can also influence decisions about transfer timing and the overall treatment process.

What Are Fresh Embryos, Frozen Embryos, and Blastocysts?

To understand these terms, it helps to start with the embryo development process after egg retrieval.

The day of egg retrieval is generally designated as Day 0 (D0). After retrieval, the laboratory performs fertilization through conventional in vitro fertilization or intracytoplasmic sperm injection (ICSI). The fertilized eggs then begin dividing and developing. By the third day after retrieval, they typically develop into cleavage-stage embryos consisting of multiple cells, commonly referred to as D3 embryos.

If the embryos remain in laboratory culture for another two to three days, they may develop into blastocysts, usually on Day 5 or Day 6 after egg retrieval. At this stage, the embryo has developed distinct inner cell mass and trophectoderm structures, representing a more advanced developmental stage than a D3 embryo.

The distinction between fresh and frozen embryos is primarily based on whether the embryos have undergone cryopreservation. Whether they are D3 embryos or D5 blastocysts, embryos transferred without prior freezing are considered fresh embryo transfers. Embryos that are cryopreserved and later thawed for transfer are considered frozen embryo transfers.

What Is the Difference Between D3 Embryo and D5 Blastocyst Transfer?

The main difference between D3 embryos and D5 blastocysts lies in their duration of in vitro culture and developmental stage. Blastocysts have undergone a longer period of development, allowing the laboratory to observe their progression further and help assess their developmental potential.

Blastocyst transfer also corresponds more closely to the developmental stage at which an embryo naturally enters the uterus during conception. For patients whose embryos develop successfully to the blastocyst stage, D5 blastocyst transfer is a common treatment option.

Dr. Nathan Zhang, an expert in assisted reproductive medicine and founder of IVF USA, explains that IVF treatment in the United States typically involves culturing embryos to the blastocyst stage and combining this process with PGT testing to assess their chromosomal status. Embryo transfer is then planned based on the test results and the condition of the endometrium. Combining embryo culture with genetic testing provides additional information to support transfer decisions.

Fresh Embryo Transfer or Frozen Embryo Transfer: Which Is More Suitable?

The main advantage of fresh embryo transfer is that the embryos do not need to undergo cryopreservation after egg retrieval. Transfer can take place within the same treatment cycle, resulting in a relatively shorter overall waiting period.

However, medications used during ovarian stimulation may affect hormone levels and the endometrial environment. For some patients, the endometrium may not be suitable for immediate transfer during the fresh cycle. In such cases, the embryos can first be frozen, and transfer can be scheduled after the patient's physical condition and endometrial environment have been adjusted.

Frozen embryo transfer allows embryos to be preserved and gives doctors more time to assess and prepare the endometrium. For patients undergoing PGT testing, embryos are generally cryopreserved first, and transfer is arranged after the test results become available. Modern vitrification technology has also significantly improved the effectiveness of embryo cryopreservation.

In clinical practice, both fresh and frozen embryo transfers have their appropriate applications. The choice should take into account hormone levels after ovarian stimulation, endometrial condition, embryo development, and PGT testing arrangements, rather than simply comparing which approach is better.

The IVF USA team, founded by Dr. Nathan Zhang, has provided overseas assisted reproductive consultation services for more than ten years, offering U.S. egg freezing, U.S. IVF, and third-party reproductive services to individuals and families in need. With nearly 20 years of experience in the overseas assisted reproduction field, IVF USA recognized the growing diversity and individualization of reproductive needs and established an early presence in the Mexican market, becoming the Chinese representative of Power Fertility Center in Mexico (POWER IVF). Dr. Nathan Zhang's services have now expanded beyond the United States to include IVF and egg freezing in Mexico, IVF and egg freezing in Japan and Thailand, as well as services in Taiwan and Hong Kong. Together, we can prepare for the future and look forward to welcoming new possibilities.